[1]
Syvolap, V.V. and Gerasko, M.P. 2014. New features correction of the dyslipidemia in patients with diabetes mellitus and metabolic cardiovascular risk factors. Current issues in pharmacy and medicine: science and practice. 1 (May 2014). DOI:https://doi.org/10.14739/2409-2932.2014.1.24831.